Deal Announcements

Cerexa Acquired by Forest Labs for $580 Million

Thursday, December 14, 2006 7:00:00 AM PDT | VentureDeal Staff

ALAMEDA, CA --  Cerexa Inc. announced a formal agreement for its acquisition by Forest Laboratories (NYSE: FRX) for $480 million in cash plus up to $100 million in a milestone payment.

Forest is acquiring Cerexa for its Ceftaroline drug, a promising antibiotic in late stage clinical trials, and other promising candidates.

Investors in Cerexa were Canaan Partners, OrbiMed Advisors, Frazier Healthcare Ventures, New Leaf Venture Partners, Pappas Ventures, Montreux Equity Partners, EGS Healthcare Capital Partners and Sears Capital Management.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1